HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J M Hallenbeck Selected Research

J M Hallenbeck Research Topics

Disease

5Stroke (Strokes)
10/2004 - 01/2000
5Ischemia
03/2001 - 01/2000
3Brain Ischemia (Cerebral Ischemia)
01/2002 - 03/2001
3Infarction (Infarctions)
11/2001 - 07/2000
2Ischemic Stroke
10/2004 - 11/2001
2Brain Injuries (Brain Injury)
04/2001 - 12/2000
2Hypoxia (Hypoxemia)
03/2001 - 01/2001
1Clinical Deterioration
11/2001
1Hemorrhage
04/2001
1Paralysis (Palsy)
04/2001
1Thrombosis (Thrombus)
04/2001
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
01/2001
1No-Reflow Phenomenon
05/2000
1Inflammation (Inflammations)
01/2000

Drug/Important Bio-Agent (IBA)

4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2001 - 12/2000
3CytokinesIBA
04/2001 - 01/2000
3CeramidesIBA
03/2001 - 01/2001
2Glial Fibrillary Acidic ProteinIBA
01/2002 - 07/2000
1Biomarkers (Surrogate Marker)IBA
10/2004
1AntibodiesIBA
11/2001
1Peroxidase (Myeloperoxidase)IBA
11/2001
1P-SelectinIBA
11/2001
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2001
1Cell Adhesion MoleculesIBA
11/2001
1Immunoglobulin G (IgG)IBA
11/2001
1Immunoglobulins (Immunoglobulin)IBA
11/2001
1E-SelectinIBA
11/2001
1enlimomabIBA
11/2001
1BCG lipopolysaccharideIBA
04/2001
1LipopolysaccharidesIBA
03/2001
1N-acetylsphingosineIBA
03/2001
12,3-N-octanoylsphingosineIBA
03/2001
1Oxygen (Dioxygen)IBA
01/2001
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2000
1IntegrinsIBA
05/2000
1FibrinIBA
05/2000
1Leukocyte-Adhesion ReceptorsIBA
05/2000

Therapy/Procedure

1Therapeutics
01/2000